Last 48 quarters of trend data · Healthcare · Healthcare Providers
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -0.58 | — | 1.64 | — | 0.95 | 0.84 | 0.41 | — | — | — | — | — | 2.24 | — | — | — | 0.34 | — | — | 12.90 | 2.48 |
| — | — | +302.6% | — | — | — | — | — | — | — | — | — | +558.3% | — | — | — | -86.3% | — | — | — | +243.6% | |
| P/S Ratio | 0.01 | 0.04 | 0.03 | 0.01 | 0.03 | 0.04 | 0.04 | 0.03 | 0.03 | 0.07 | 0.04 | 0.04 | 0.03 | 0.03 | 0.05 | 0.05 | 0.04 | 0.02 | 0.04 | 0.12 | 0.14 |
| — | +0.5% | -23.7% | -71.3% | +12.2% | -46.0% | +3.5% | -22.4% | -6.9% | +111.7% | -23.3% | -28.4% | -27.4% | +33.8% | +11.9% | -58.1% | -67.4% | -81.3% | -75.4% | -13.5% | +90.0% | |
| P/B Ratio | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/FCF | — | 1.45 | 9.46 | — | 0.61 | 27.08 | — | 2.56 | 0.92 | — | 8.55 | 38.29 | — | — | — | — | — | 1.58 | — | 94.96 | — |
| — | -94.6% | — | — | -33.6% | — | — | -93.3% | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | 9.81 | 5.29 | 1.48 | — | 8.23 | 4.65 | 7.65 | 7.65 | — | 8.65 | 9.13 | 8.53 | 10.61 | 8.76 | 9.47 | 11.46 | 9.28 | 12.97 | 8.78 | 7.86 |
| — | +19.3% | +13.7% | -80.6% | — | — | -46.2% | -16.2% | -10.2% | — | -1.3% | -3.5% | -25.6% | +14.3% | -32.5% | +7.8% | +45.8% | +36.6% | +73.8% | +25.2% | +16.1% | |
| EV / EBIT | — | 16.32 | 12.11 | 0.79 | 6.64 | 13.50 | 10.52 | 11.45 | 10.93 | 52.01 | 12.69 | 12.74 | 12.60 | 16.09 | 13.87 | 17.22 | 13.15 | 23.26 | 29.45 | 15.27 | 9.32 |
| — | +20.9% | +15.1% | -93.1% | -39.2% | -74.1% | -17.1% | -10.1% | -13.3% | +223.2% | -8.5% | -26.0% | -4.2% | -30.8% | -52.9% | +12.8% | +41.1% | +131.8% | +177.5% | +24.2% | -13.2% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 8.7% | 5.8% | 69.5% | 96.6% | -134.6% | 85.1% | 42.7% | 41.1% | 42.7% | 40.8% | 42.3% | 40.9% | 41.3% | 40.8% | 40.9% | 39.8% | 40.9% | 39.0% | 39.3% | 41.4% | 42.5% |
| — | -93.2% | +63.0% | +135.1% | -415.2% | +108.4% | +0.9% | +0.4% | +3.5% | +0.1% | +3.5% | +2.9% | +0.8% | +4.5% | +4.1% | -3.9% | -3.8% | -2.7% | -4.9% | +2.3% | +7.2% | |
| Operating Margin | -79.4% | 5.8% | 9.6% | 13.5% | -352.7% | 7.9% | 16.3% | 9.0% | 8.5% | -6.6% | 7.6% | 7.4% | 10.3% | 5.6% | 7.9% | 6.8% | 7.3% | 6.7% | 4.1% | 8.7% | 13.1% |
| — | -26.3% | -41.4% | +50.4% | -4242.0% | +218.7% | +115.6% | +22.2% | -17.1% | -218.3% | -4.0% | +8.9% | +41.0% | -16.9% | +94.7% | -22.1% | -44.4% | -38.2% | -61.2% | -19.8% | -6.2% | |
| Net Margin | 4.1% | -3.1% | 1.7% | -5.0% | 3.5% | 4.2% | 9.0% | -0.4% | -2.1% | -12.7% | -0.4% | -1.3% | 1.5% | -2.9% | -1.2% | -1.6% | 13.2% | -1.4% | -11.1% | -0.0% | 5.5% |
| — | -174.1% | -80.9% | -1119.3% | +265.2% | +133.3% | +2274.2% | +68.5% | -245.1% | -329.1% | +66.1% | +20.4% | -88.8% | -112.4% | +89.0% | -5011.8% | +139.9% | -139.0% | -5669.5% | +98.5% | -44.8% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| ROA | 3.7% | -0.7% | 0.6% | -4.6% | 0.8% | 1.0% | 2.0% | -0.1% | -0.5% | -2.8% | -0.1% | -0.3% | 0.3% | -0.6% | -0.3% | -0.3% | 2.8% | -0.3% | -2.2% | -0.0% | 1.2% |
| — | -173.2% | -73.0% | -4872.0% | +266.2% | +135.0% | +2371.2% | +67.3% | -255.2% | -344.9% | +65.3% | +18.4% | -88.5% | -121.4% | +87.9% | -5175.8% | +143.4% | -139.4% | -5670.7% | +98.4% | -39.7% | |
| ROIC | -70.1% | 1.3% | 3.2% | 12.6% | -79.6% | 1.8% | 3.8% | 2.0% | 1.9% | -1.4% | 1.6% | 1.5% | 2.1% | 1.1% | 1.6% | 1.4% | 1.5% | 1.4% | 0.8% | 1.7% | 2.9% |
| — | -26.5% | -14.8% | +520.4% | -4216.2% | +230.3% | +140.9% | +32.6% | -9.9% | -223.7% | -1.2% | +12.2% | +42.1% | -16.8% | +106.9% | -21.9% | -48.0% | -45.3% | -66.4% | -27.1% | -9.5% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Debt / EBITDA | — | 38.38 | 20.53 | 6.12 | — | 32.03 | 18.59 | 30.79 | 29.73 | — | 33.48 | 35.34 | 33.08 | 41.47 | 33.80 | 36.44 | 44.24 | 37.18 | 51.34 | 32.47 | 28.62 |
| — | +19.8% | +10.4% | -80.1% | — | — | -44.5% | -12.9% | -10.1% | — | -0.9% | -3.0% | -25.2% | +11.5% | -34.2% | +12.2% | +54.6% | +39.4% | +82.5% | +19.8% | -0.7% | |
| Current Ratio | 1.46 | 1.48 | 1.53 | 1.47 | 1.46 | 1.47 | 1.59 | 1.44 | 1.41 | 1.46 | 1.47 | 1.49 | 1.50 | 1.51 | 1.54 | 1.46 | 1.41 | 1.37 | 1.45 | 1.49 | 1.47 |
| — | +1.1% | -4.1% | +2.2% | +4.0% | +0.4% | +8.2% | -3.3% | -6.0% | -3.3% | -4.2% | +1.8% | +6.2% | +10.2% | +6.0% | -1.7% | -4.2% | +1.5% | +2.7% | -1.9% | -8.1% | |
| Quick Ratio | 1.32 | 1.48 | 1.39 | 1.36 | 1.32 | 1.32 | 1.45 | 1.30 | 1.27 | 1.32 | 1.32 | 1.33 | 1.34 | 1.36 | 1.38 | 1.30 | 1.25 | 1.22 | 1.30 | 1.34 | 1.32 |
| — | +12.5% | -4.0% | +4.9% | +4.1% | +0.3% | +10.2% | -2.5% | -5.8% | -3.3% | -4.3% | +2.6% | +7.7% | +11.2% | +6.3% | -2.8% | -5.5% | -1.5% | +0.0% | -3.9% | -10.9% | |
| Interest Coverage | 1.83 | 0.80 | 1.05 | 15.48 | 2.00 | 0.99 | 1.28 | 1.19 | 1.31 | 0.29 | 1.15 | 1.18 | 1.19 | 0.96 | 1.13 | 0.91 | 1.19 | 0.63 | 0.51 | 1.06 | 1.72 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying CYH stock.
Community Health Systems, Inc.'s current P/E is -0.6x. The average P/E over the last 2 quarters is 1.3x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Community Health Systems, Inc.'s current operating margin is -79.4%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Community Health Systems, Inc.'s business trajectory between earnings reports.